PE20242300A1 - Compuestos, procedimiento de produccion de compuestos, extracto enriquecido, fracciones activas de extractos enriquecidos, procedimiento de produccion de extractos enriquecidos, metodo para seleccionar biomasa vegetal para produccion, composicion y uso de extractos enriquecidos para el tratamiento de trastornos inmunologicos - Google Patents
Compuestos, procedimiento de produccion de compuestos, extracto enriquecido, fracciones activas de extractos enriquecidos, procedimiento de produccion de extractos enriquecidos, metodo para seleccionar biomasa vegetal para produccion, composicion y uso de extractos enriquecidos para el tratamiento de trastornos inmunologicosInfo
- Publication number
- PE20242300A1 PE20242300A1 PE2024002048A PE2024002048A PE20242300A1 PE 20242300 A1 PE20242300 A1 PE 20242300A1 PE 2024002048 A PE2024002048 A PE 2024002048A PE 2024002048 A PE2024002048 A PE 2024002048A PE 20242300 A1 PE20242300 A1 PE 20242300A1
- Authority
- PE
- Peru
- Prior art keywords
- production
- enriched
- procedure
- extracts
- enriched extracts
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/94—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
- C07C69/757—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/85—Verbenaceae (Verbena family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/42—Separation; Purification; Stabilisation; Use of additives
- C07C51/47—Separation; Purification; Stabilisation; Use of additives by solid-liquid treatment; by chemisorption
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
- C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
- C07C59/92—Unsaturated compounds containing keto groups containing —CHO groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/10—Systems containing only non-condensed rings with a five-membered ring the ring being unsaturated
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Transplantation (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Medical Informatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrane Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
Abstract
Se describen compuestos aislados y un procedimiento de produccion de compuestos y extractos con actividad inmunosupresora, de plantas del genero Stachytarpheta. Tambien describe composiciones y su usa para el tratamiento de trastornos inmunologicos. En particular, se refiere a compuestos que comprenden la formula general (I), (II) y (III), en donde R es H, OH, OGIyc (glicosido); R1, R1', R1'' corresponden a H, OH; R2 es H, COOH, COOCH3, CH3, CHO; R3 es H, OH, CH3; R4, R4' corresponden a H, OH, CH2OH, CH3; R5, R5' corresponden a H, CH3, COOCH3, CHO, CH2OH; R6 es CHO, COOH, COOCH3; R7 es H, CH3; R8, R8', R8'' corresponden a CHO, CH3, CH2OH, COOH y los enlaces discontinuos representan enlaces simples (C-C) o dobles (C=C) entre carbonos (hasta dos dobles enlaces por estructura).
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BR102017003318-0A BR102017003318A2 (pt) | 2017-02-17 | 2017-02-17 | compostos, processo de produção de compostos, extrato enriquecido, frações ativas de extrato enriquecido, processo de produção de extrato enriquecido, método de seleção de biomassa vegetal para produção de extrato enriquecido, composição e uso para tratamento de desordens imunológicas |
| PCT/BR2018/050037 WO2018148816A2 (en) | 2017-02-17 | 2018-02-19 | Compounds, process of production of compounds, enriched extract, enriched extract active fractions, enriched extract process of production, method for selecting vegetal biomass for enriched extract production, composition and use for treatment of immunological disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20242300A1 true PE20242300A1 (es) | 2024-12-11 |
Family
ID=61282932
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2019001711A PE20200449A1 (es) | 2017-02-17 | 2018-02-19 | Compuestos, procedimiento de produccion de compuestos, extracto enriquecido, fracciones activas de extractos enriquecidos, procedimiento de produccion de extractos enriquecidos, metodo para seleccionar biomasa vegetal para produccion, composicion y uso de extractos enriquecidos para el tratamiento de trastornos inmunologicos |
| PE2024002048A PE20242300A1 (es) | 2017-02-17 | 2018-02-19 | Compuestos, procedimiento de produccion de compuestos, extracto enriquecido, fracciones activas de extractos enriquecidos, procedimiento de produccion de extractos enriquecidos, metodo para seleccionar biomasa vegetal para produccion, composicion y uso de extractos enriquecidos para el tratamiento de trastornos inmunologicos |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2019001711A PE20200449A1 (es) | 2017-02-17 | 2018-02-19 | Compuestos, procedimiento de produccion de compuestos, extracto enriquecido, fracciones activas de extractos enriquecidos, procedimiento de produccion de extractos enriquecidos, metodo para seleccionar biomasa vegetal para produccion, composicion y uso de extractos enriquecidos para el tratamiento de trastornos inmunologicos |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US20200231561A1 (es) |
| EP (2) | EP3583103B1 (es) |
| JP (2) | JP7349362B2 (es) |
| KR (2) | KR102882868B1 (es) |
| CN (1) | CN110475768B (es) |
| AU (2) | AU2018221956B2 (es) |
| BR (2) | BR102017003318A2 (es) |
| CA (2) | CA3052713A1 (es) |
| CL (1) | CL2019002309A1 (es) |
| CO (1) | CO2019008891A2 (es) |
| CY (1) | CY1125187T1 (es) |
| DK (1) | DK3583103T3 (es) |
| EC (1) | ECSP19058322A (es) |
| ES (1) | ES2909387T3 (es) |
| HR (1) | HRP20220377T1 (es) |
| IL (2) | IL268732B2 (es) |
| LT (1) | LT3583103T (es) |
| MX (2) | MX2019009655A (es) |
| NZ (1) | NZ756074A (es) |
| PE (2) | PE20200449A1 (es) |
| PL (1) | PL3583103T3 (es) |
| PT (1) | PT3583103T (es) |
| RS (1) | RS63162B1 (es) |
| SA (1) | SA519402443B1 (es) |
| SG (1) | SG11201907375VA (es) |
| SI (1) | SI3583103T1 (es) |
| SM (1) | SMT202200121T1 (es) |
| WO (1) | WO2018148816A2 (es) |
| ZA (2) | ZA201906106B (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115304652A (zh) * | 2022-07-25 | 2022-11-08 | 福建华闽晟业生物科技有限公司 | 一种利用巨菌草制备野芝麻新甙的方法 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3703543A (en) * | 1969-11-05 | 1972-11-21 | American Home Prod | Hydroxamic acids of alicyclic amino acids |
| ATE715T1 (de) * | 1978-06-03 | 1982-03-15 | Institut De Recherches Chimiques Et Biologiques Appliquees (I.R.C.E.B.A.) Societe A Responsabilite Limitee Dite: | Arzneimittel mit einem gehalt an einem cyclopentylaldehyd-derivat. |
| DE3030477C2 (de) * | 1980-08-12 | 1986-10-16 | Dr. Willmar Schwabe GmbH & Co, 7500 Karlsruhe | Iridoid-Derivate, Verfahren zu ihrer Herstellung und deren Verwendung |
| JPH0366682A (ja) * | 1989-08-04 | 1991-03-22 | Tsumura & Co | 新規イリドイド誘導体 |
| US5272172A (en) * | 1990-10-09 | 1993-12-21 | Tsumura & Co. | Iridoid derivatives and the use thereof as a drug |
| DE19644422C2 (de) * | 1996-10-25 | 2000-06-15 | Stefan Schulz | Verwendung von Terpenen zur Behandlung von Autoimmunkrankheiten und bei Transplantat-Abstoßungsreaktionen |
| EP1145709A1 (de) * | 2000-04-14 | 2001-10-17 | Laboratoires Serobiologiques | Verwendung von Naturstoffen zur Herstellung von kosmetischen Zubereitungen |
| AU2003224361B2 (en) * | 2002-05-10 | 2008-01-31 | Council Of Scientific And Industrial Research | Hepatoprotective activity of 2'-p-Hydroxybenzoylmussaenosidic acid |
| EP1371372A1 (de) * | 2002-06-08 | 2003-12-17 | Cognis Iberia, S.L. | Verwendung von Wirkstoffgemischen enthaltend Tocopherole und Extrakte des Harpagophytum procumbens zur Herstellung eines Medikamentes gegen rheumatische Arthritis |
| JP2008024670A (ja) * | 2006-07-24 | 2008-02-07 | Daiwa Kagaku Kogyo Kk | 害虫駆除剤 |
| BRPI0719505A2 (pt) * | 2006-12-21 | 2013-12-10 | Du Pont | "Processos de preparação de óleo de erva dos gatos hidrogenado" |
| BRPI0700767B8 (pt) * | 2007-02-15 | 2021-05-25 | Ache Laboratorios Farmaceuticos Sa | composição farmacêutica, produto farmaceutico, processo para obtenção de compostos farmaceuticos e uso de tais compostos para o tratamento do vitiligo |
| WO2013032308A2 (ko) * | 2011-09-02 | 2013-03-07 | 동국대학교 산학협력단 | 라카아제를 이용한 새로운 효소형 시간-온도 이력지시계 |
| CN103120699B (zh) * | 2011-11-18 | 2017-04-19 | 天津市国际生物医药联合研究院 | 环烯醚萜类化合物在制备抗sars的药物中的应用 |
| CN103690551A (zh) * | 2013-07-18 | 2014-04-02 | 江苏大学 | 猪殃殃中环烯醚萜苷提取物及其提取方法和医药用途 |
| DE102015102020A1 (de) * | 2015-02-12 | 2016-08-18 | Renate Wilmanowicz | Immunologisch aktives Phyto-Gemisch und seine Anwendung bei der Prävention und in einem Verfahren zur Behandlung von Effloreszenzen |
-
2017
- 2017-02-17 BR BR102017003318-0A patent/BR102017003318A2/pt active Search and Examination
-
2018
- 2018-02-19 KR KR1020197026718A patent/KR102882868B1/ko active Active
- 2018-02-19 JP JP2019544005A patent/JP7349362B2/ja active Active
- 2018-02-19 EP EP18707229.3A patent/EP3583103B1/en active Active
- 2018-02-19 CA CA3052713A patent/CA3052713A1/en active Pending
- 2018-02-19 MX MX2019009655A patent/MX2019009655A/es unknown
- 2018-02-19 BR BR112019017128-2A patent/BR112019017128A2/pt active Search and Examination
- 2018-02-19 HR HRP20220377TT patent/HRP20220377T1/hr unknown
- 2018-02-19 WO PCT/BR2018/050037 patent/WO2018148816A2/en not_active Ceased
- 2018-02-19 EP EP21215133.6A patent/EP4001270A1/en active Pending
- 2018-02-19 AU AU2018221956A patent/AU2018221956B2/en active Active
- 2018-02-19 IL IL268732A patent/IL268732B2/en unknown
- 2018-02-19 KR KR1020257031344A patent/KR20250145126A/ko active Pending
- 2018-02-19 CA CA3259255A patent/CA3259255A1/en active Pending
- 2018-02-19 SI SI201830594T patent/SI3583103T1/sl unknown
- 2018-02-19 DK DK18707229.3T patent/DK3583103T3/da active
- 2018-02-19 NZ NZ756074A patent/NZ756074A/en unknown
- 2018-02-19 ES ES18707229T patent/ES2909387T3/es active Active
- 2018-02-19 SM SM20220121T patent/SMT202200121T1/it unknown
- 2018-02-19 US US16/486,683 patent/US20200231561A1/en active Pending
- 2018-02-19 PE PE2019001711A patent/PE20200449A1/es unknown
- 2018-02-19 RS RS20220241A patent/RS63162B1/sr unknown
- 2018-02-19 PL PL18707229.3T patent/PL3583103T3/pl unknown
- 2018-02-19 CN CN201880018995.0A patent/CN110475768B/zh active Active
- 2018-02-19 IL IL313974A patent/IL313974A/en unknown
- 2018-02-19 PE PE2024002048A patent/PE20242300A1/es unknown
- 2018-02-19 LT LTEPPCT/BR2018/050037T patent/LT3583103T/lt unknown
- 2018-02-19 SG SG11201907375VA patent/SG11201907375VA/en unknown
- 2018-02-19 PT PT187072293T patent/PT3583103T/pt unknown
-
2019
- 2019-08-13 MX MX2022012282A patent/MX2022012282A/es unknown
- 2019-08-14 CL CL2019002309A patent/CL2019002309A1/es unknown
- 2019-08-14 EC ECSENADI201958322A patent/ECSP19058322A/es unknown
- 2019-08-15 SA SA519402443A patent/SA519402443B1/ar unknown
- 2019-08-15 CO CONC2019/0008891A patent/CO2019008891A2/es unknown
- 2019-09-16 ZA ZA2019/06106A patent/ZA201906106B/en unknown
-
2022
- 2022-03-16 AU AU2022201835A patent/AU2022201835B2/en active Active
- 2022-03-21 CY CY20221100223T patent/CY1125187T1/el unknown
-
2023
- 2023-01-25 JP JP2023009384A patent/JP7685540B2/ja active Active
-
2025
- 2025-02-28 ZA ZA2025/01840A patent/ZA202501840B/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP22050936A (es) | Compuestos tric?clicos sustituidos | |
| CL2020000632A1 (es) | Composición y método para el tratamiento del autismo. | |
| DOP2018000257A (es) | Piridinas sustituidas con heteroarilo y métodos de uso | |
| CR20190063A (es) | 3-metil pirazinas 2,5-disustituídas y 3-metil pirazinas 2,5,6-trisustituídas como inhibidores alostéricos de shp2 | |
| MX2019013561A (es) | Compuestos de pirrolopiridina-anilina para el tratamiento de trastornos dermicos. | |
| CL2009000429A1 (es) | Compuestos derivados de carbamoil-heterociclos fusionados, en especial pirrolo[3,2-c]piridin-2-carboxamidas, inhibidores de smo; composicion farmaceutica que comprende dichos compuestos; y uso en la profilaxis o tratamiento del cancer. | |
| CL2020002089A1 (es) | Prevenir o reducir el crecimiento de las plantas por biocementación. | |
| CO2019007409A2 (es) | Derivados de la pirimidin enona tricíclica para la inhibición de rorγ y otros usos | |
| CL2007001711A1 (es) | Compuestos derivados de pirazolopiridina sustituida;composicion farmaceutica que los comprende;metodo de preparacion de los compuestos ,compuestos intermediarios;y su uso en el tratamiento de enfermedades,tales como tumores,artritis reumatoide,enfermedades del crecimiento vascular desregulado, entre otras. | |
| CL2017000293A1 (es) | Compuestos derivados de benzofurano sustituido en posición 6 por un radical que contiene boro; composición farmacéutica que los comprende; uso en el tratamiento de la hepatitis c (divisional del cl 393-2014) | |
| AR115081A1 (es) | Aislados de microbacterias y sus usos | |
| MX2022007671A (es) | Compuestos antihelminticos que comprenden una estructura de azaindoles. | |
| GT201700126A (es) | Ácidos piridil-cicloalquil-carboxílicos sustituidos composiciones que los contienen y usos de los mismos | |
| AR128109A1 (es) | Spiros y análogos relacionados para inhibir yap / taz-tead | |
| MX2024007929A (es) | Tetrahidropirazolopirimidinas y analogos relacionados para la inhibicion de yap/taz-tead. | |
| CO2024015524A2 (es) | Compuestos aromáticos que contienen boro y análogos de insulina relacionados | |
| CL2025000161A1 (es) | Compuestos cíclicos y métodos de utilización de estos. | |
| CL2024001635A1 (es) | Compuestos de diazaspiro sustituidos con carbonilo y su uso | |
| SA522432999B1 (ar) | C-17 مركبات تراي تريبينويد تخليقية ذات مجموعات استبدال اساسها نيتروجين عند وطرق استخدامها | |
| PE20242300A1 (es) | Compuestos, procedimiento de produccion de compuestos, extracto enriquecido, fracciones activas de extractos enriquecidos, procedimiento de produccion de extractos enriquecidos, metodo para seleccionar biomasa vegetal para produccion, composicion y uso de extractos enriquecidos para el tratamiento de trastornos inmunologicos | |
| MX2014000344A (es) | Antagonistas de trpv1 que incluyen sustituyente dihidroxi y sus usos. | |
| CL2021003384A1 (es) | Composición y método para mejorar el crecimiento de las plantas | |
| CL2008003154A1 (es) | Proceso de obtencion de un extracto estandarizado de aleuterites moluccana; extracto estandarizado de aleurites moluccana; composicion farmaceutica que comprende el extracto; uso del extracto para tratar condiciones de dolor. | |
| MX2014010926A (es) | Composicion herbaria para el tratamiento de transtornos metabolicos. | |
| AR110750A1 (es) | Método para mejorar la salud de las plantas y el desarrollo de las raíces |